share_log

药明生物(02269.HK)获董事长李革增持144.5万股

Wuxi Bio (02269.HK) received shareholding of 1.445 million shares from Director Li Ge.

Gelonghui Finance ·  Jun 26 06:57

According to the latest equity disclosure information from the HKEX, on June 24, 2024, Wuxi Bio(02269.HK) non-executive director and chairman Li Ge increased his shareholding by 1.445 million shares on the exchange at an average price of HKD 11.5735 per share, involving approximately HKD 16.7237 million.

After the shareholding increase, Li Ge's latest shareholding number is 592,902,633 shares, and the shareholding ratio has increased from 14.24% to 14.28%.

big

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment